American Healthcare REIT (NYSE:AHR) Announces Quarterly Earnings Results

Key Points

• American Healthcare REIT reported a quarterly earnings per share (EPS) of $0.42, surpassing the consensus estimate of $0.40, with revenue of $542.50 million, up 7.5% year-over-year.
• The company updated its fiscal year 2025 guidance to an EPS range of 1.640-1.680.
• A dividend of $0.25 per share was paid, translating to an annual yield of 2.5%, despite a negative payout ratio of -370.37%.

American Healthcare REIT (NYSE:AHR - Get Free Report) released its earnings results on Thursday. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.40 by $0.02, Zacks reports. The firm had revenue of $542.50 million for the quarter, compared to analysts' expectations of $539.49 million. American Healthcare REIT had a negative return on equity of 1.46% and a negative net margin of 1.56%. The business's quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.33 EPS. American Healthcare REIT updated its FY 2025 guidance to 1.640-1.680 EPS.

American Healthcare REIT Stock Performance

Shares of NYSE:AHR traded up $0.66 during midday trading on Friday, reaching $40.52. 1,697,790 shares of the company traded hands, compared to its average volume of 1,127,625. The company has a quick ratio of 0.38, a current ratio of 0.38 and a debt-to-equity ratio of 0.45. American Healthcare REIT has a 12 month low of $16.41 and a 12 month high of $41.50. The firm has a market capitalization of $6.46 billion, a price-to-earnings ratio of -184.19, a price-to-earnings-growth ratio of 2.28 and a beta of 1.08. The firm's fifty day moving average price is $36.87 and its two-hundred day moving average price is $32.70.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 18th. Investors of record on Monday, June 30th were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, June 30th. American Healthcare REIT's payout ratio is presently -370.37%.

Insider Buying and Selling

In related news, CIO Stefan K.L. Oh sold 3,860 shares of the business's stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total transaction of $139,346.00. Following the completion of the transaction, the executive directly owned 95,671 shares in the company, valued at $3,453,723.10. The trade was a 3.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.92% of the stock is currently owned by insiders.

Institutional Investors Weigh In On American Healthcare REIT

Institutional investors have recently bought and sold shares of the stock. Acadian Asset Management LLC purchased a new stake in American Healthcare REIT during the 1st quarter valued at about $185,000. NewEdge Advisors LLC raised its position in American Healthcare REIT by 9.4% during the 1st quarter. NewEdge Advisors LLC now owns 23,509 shares of the company's stock valued at $712,000 after purchasing an additional 2,011 shares during the last quarter. AQR Capital Management LLC raised its position in American Healthcare REIT by 170.1% during the 1st quarter. AQR Capital Management LLC now owns 25,275 shares of the company's stock valued at $766,000 after purchasing an additional 15,918 shares during the last quarter. Focus Partners Wealth raised its position in American Healthcare REIT by 6.6% during the 1st quarter. Focus Partners Wealth now owns 25,809 shares of the company's stock valued at $782,000 after purchasing an additional 1,591 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in American Healthcare REIT by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 90,521 shares of the company's stock valued at $2,743,000 after purchasing an additional 3,954 shares during the last quarter. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on AHR shares. Baird R W upgraded American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. Morgan Stanley increased their price target on American Healthcare REIT from $37.00 to $45.00 and gave the company an "overweight" rating in a research note on Tuesday, May 20th. Jefferies Financial Group began coverage on American Healthcare REIT in a research note on Monday, April 28th. They issued a "buy" rating and a $37.00 price target on the stock. Scotiabank began coverage on American Healthcare REIT in a research note on Monday, June 30th. They issued a "sector outperform" rating and a $42.00 price target on the stock. Finally, Truist Financial increased their price target on American Healthcare REIT from $32.00 to $38.00 and gave the company a "buy" rating in a research note on Monday, June 9th. Ten equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $38.11.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.